SCHEMBL7974249

SCHEMBL7974249

Cc1cccc(Cn2cnc3[nH]c(-c4cccc(O)c4)nc(=O)c32)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
HPGD P15428 3/20 0.40
TSHR P16473 3/20 0.40
CNOT7 Q9UIV1 2/20 0.40
LMNA P02545 2/20 0.40
PARN O95453 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ACP1 P24666 1/20 0.40
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
RECQL P46063 1/20 0.39
MGAM O43451 1/20 0.38
GAA P10253 1/20 0.38
SI P14410 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985568 0.91 CNOT7 (0.41) CYP11B1CYP11B2HPGDTSHRCNOT7
SCHEMBL7974270 0.90 ALDH1A1 (0.46) ALDH1A1CYP11B1CYP11B2HPGDTSHR
SCHEMBL7985342 0.90 CNOT7 (0.51) ALDH1A1HPGDCNOT7PARNSMN1; SMN2
SCHEMBL7991561 0.89 HPGD (0.43) ALDH1A1CYP11B1CYP11B2HPGDTSHR
SCHEMBL7975243 0.88 HTT (0.44) ALDH1A1CYP11B1CYP11B2HPGDTSHR
SCHEMBL7991647 0.88 SMN1; SMN2 (0.44) CNOT7PARNHTTSMN1; SMN2ACP1
SCHEMBL7988962 0.88 GRIN1 (0.44) ALDH1A1CYP11B1CYP11B2HPGDTSHR
SCHEMBL7991638 0.88 GRIN1 (0.42) CNOT7PARNACP1MTORIDO1
SCHEMBL7988597 0.88 PARN (0.48) ALDH1A1CYP11B1CYP11B2HPGDCNOT7
SCHEMBL7984697 0.87 TP53 (0.48) LMNAGAAMTORMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed